Association of soluble HLA-G and HLA-G 14bp ins /del Polymorphism in some Iraqi patients with Breast Cancer
DOI:
https://doi.org/10.37506/ijfmt.v14i3.10504Keywords:
Human leucocyte antigen-G, Gene polymorphism, Breast cancerAbstract
Human leukocyte antigen-G is known to be implicated in a tumor-driven immune escape mechanism in
malignancies. The main objective of the study is to evaluate the HLA-G 14-bp polymorphism in the 3?-
untranslated region of the HLA-G gene in that associated with the susceptibility to breast cancer patients.
This study has been done on 60 BC patients & 30 Benign tumor and30 control groups. Estimation of
sHLA-G markers was assayed by using ELISA technique. Thus, polymorphism of HLAG HLA-G 14-bp
were detected by PCR methods. The plasma levels of HLA-G shows a significant elevation in BC patients
compared to benign breast tumour and controls (32.79±0.9vs. 13.84 ±0.30 and 12.72 ±0.45 ng/ml, P?0.05).
There was a significant difference between newly diagnosed breast cancer patients and healthy control groups
in homozygous genotype HLA-G 14-bp del/del genotyping (66.7% vs. 36.7%; OR=3.45; P?0.01). While,
no significant differences in the homozygous genotypes Ins/ins frequency were observed between patients
with breast cancer (6.6%) and the healthy control group (0.0%) (OR=3.45, P?0.001). There was a significant
increase frequency of heterozygous genotype Ins/del in controls compared to patients (63.3%vs.26.7%).
No significant difference was found between the patients and control groups at HLA-G 14bp insertion and
deletion allelic frequency.
Downloads
Published
How to Cite
Issue
Section
License
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions